Financial News
All News about Kiniksa Pharmaceuticals International Plc
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](/next-assets/images/schema-image-default.png)
Overview Of Value Stocks In The Healthcare Sector
June 05, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
A Look Into Healthcare Sector Value Stocks
May 22, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2019/07/smallcap1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/cheap-ticker-too-cheap-to-ignore.jpg)
5 Value Stocks In The Healthcare Sector
January 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/03/aapharma_7.png?width=1200&height=800&fit=crop)
Kiniksa Inks Global License Agreement With Roche For Vixarelimab
August 03, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_4937.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-min-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/image29.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_1655.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/image-sony.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9203.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2263.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7783.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2020/11/14/01/08/lab-5740505_960_720.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3605.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_9599.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_1686.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_524.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/price_targets_347.png?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/analysis-4937349_1280_23.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_6827.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_322.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-afternoon-market-update_59.jpg)
Mid-Afternoon Market Update: Dow Rises Around 150 Points; Semler Scientific Shares Slide
November 02, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_3746.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_321.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.